Sage Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Sage Therapeutics, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$78.57 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-05-03
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$78.57M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was -$58.90M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$46.09M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$59.08M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$219.28M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$118.68M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$70.68M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$27.04M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$78.57M 10-Q · filed 2018-05-03 | -$137.47M derived: sum of 2 quarters · filed 2018-05-03 | -$183.56M derived: sum of 3 quarters · filed 2018-05-03 | -$242.64M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-12-31 | -$58.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$104.99M derived: sum of 2 quarters · filed 2018-02-22 | -$164.07M derived: sum of 3 quarters · filed 2018-02-22 | -$219.28M 10-K · filed 2018-02-22 |
| 2017-09-30 | -$46.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$105.17M derived: sum of 2 quarters · filed 2017-11-02 | -$160.38M 10-Q · filed 2017-11-02 | -$194.15M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-06-30 | -$59.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$114.29M 10-Q · filed 2017-08-03 | -$148.06M derived: sum of 3 quarters · filed 2018-05-03 | -$178.86M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-03-31 | -$55.21M 10-Q · filed 2018-05-03 | -$88.99M derived: sum of 2 quarters · filed 2018-05-03 | -$119.78M derived: sum of 3 quarters · filed 2018-05-03 | -$146.45M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | -$33.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$64.57M derived: sum of 2 quarters · filed 2018-02-22 | -$91.24M derived: sum of 3 quarters · filed 2018-02-22 | -$118.68M 10-K · filed 2018-02-22 |
| 2016-09-30 | -$30.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$57.47M derived: sum of 2 quarters · filed 2017-11-02 | -$84.90M 10-Q · filed 2017-11-02 | -$103.02M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | -$26.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$54.11M 10-Q · filed 2017-08-03 | -$72.22M derived: sum of 3 quarters · filed 2018-02-22 | -$91.74M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | -$27.43M 10-Q · filed 2017-05-10 | -$45.55M derived: sum of 2 quarters · filed 2018-02-22 | -$65.07M derived: sum of 3 quarters · filed 2018-02-22 | -$83.51M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | -$18.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$37.63M derived: sum of 2 quarters · filed 2018-02-22 | -$56.08M derived: sum of 3 quarters · filed 2018-02-22 | -$70.68M 10-K · filed 2018-02-22 |
| 2015-09-30 | -$19.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$37.96M derived: sum of 2 quarters · filed 2016-11-03 | -$52.56M 10-Q · filed 2016-11-03 | -$61.23M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | -$18.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$33.05M 10-Q · filed 2016-08-09 | -$41.72M derived: sum of 3 quarters · filed 2017-02-24 | -$49.20M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | -$14.61M 10-Q · filed 2016-05-06 | -$23.27M derived: sum of 2 quarters · filed 2017-02-24 | -$30.76M derived: sum of 3 quarters · filed 2017-02-24 | -$36.03M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | -$8.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$16.15M derived: sum of 2 quarters · filed 2017-02-24 | -$21.43M derived: sum of 3 quarters · filed 2017-02-24 | -$27.04M 10-K · filed 2017-02-24 |
| 2014-09-30 | -$7.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$12.76M derived: sum of 2 quarters · filed 2015-11-06 | -$18.38M 10-Q · filed 2015-11-06 | -$23.41M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$10.89M 10-Q · filed 2015-08-12 | -$15.93M derived: sum of 3 quarters · filed 2016-02-29 | -$21.10M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$5.62M 10-Q · filed 2015-05-15 | -$10.65M derived: sum of 2 quarters · filed 2016-02-29 | -$15.83M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$10.21M derived: sum of 2 quarters · filed 2016-02-29 | -$17.52M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$5.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$12.48M 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | -$7.31M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | -$8.93M 10-K · filed 2015-03-06 |